The Diabetes Ireland Research Alliance (DIRA) was set up in 2008 as a subsidiary of Diabetes Ireland, the national charity supporting people with diabetes in Ireland.
DIRA has the specific aim of promoting, supporting and funding research related to the causes, prevention and cure of diabetes.
The Alliance primarily funds high quality diabetes research projects in Ireland and raises the necessary funds to support these projects. DIRA invites and encourages the Irish Diabetes community to directly support global research into finding a cure for Type 1 diabetes by organising fund raising events and/or donating to DIRA.
Research Call now CLOSED. Focus of the Call: Diabetes-focused research projects which align with the mission statement of Diabetes Ireland Level of Funding: Up to €180,000 Duration of Funding: Up to 3 years.
Identifying the Aetiology of Diabetic Progenitor Cell Dysfunction In Osteoporosis” This research is led by Professor Tim O’Brien at Galway University Hospital. The goal is to enhance bone quality for people with diabetes. To read more, click on study name link above.
Peer-to-peer motivational interview intervention for smoking, alcohol and physical activity among at-risk adolescents in low SES communities. This research is led by Assoc. Prof. David Hevey, Trinity College Dublin and focuses on using peers to promote healthy behaviours in a group normally difficult to influence through regular health promoting channels. To read more, click on study name link above.
Why Me? The Diabetes – Genes This Autoimmunity and Prevention study may help find the answer.
In 2009, DIRA entered into partnership with the Juvenile Diabetes Research Foundation (JDRF) UK in order to encourage high-quality research on Type 1 diabetes in Ireland, promote Ireland as a JDRF base for international research and to directly support the global research work of JDRF. JDRF is widely acknowledged as the leading global charity funding Type 1 diabetes research.
Harnessing vascular stem cells to model and treat diabetic retinopathy Over time, uncontrolled Type 1 diabetes can lead to blood vessel damage and complications. Dr Reinhold Medina, Queen’s University, Belfast and his team are developing a way to test potential treatments for these, and investigating if stem cells could form part of one such treatment. It’s thought that up to a third of people with type 1 will develop some form of retinopathy, so it is important to find an effective way to treat and prevent the condition. Unfortunately, most currently available treatments for diabetic retinopathy focus on its later stages, by which time the person has often lost some of their sight. As a result, it would be tremendously helpful to have new treatments targeting earlier stages. Dr Medina’s project could lead to one such treatment, by improving blood vessel repair and preventing the later stages of diabetic retinopathy.